RIS Rx Appoints Stuart McGuigan to Board of Directors
RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for the world’s leading pharmaceutical manufacturers, today announced the appointment of Stuart McGuigan to its Board of Directors.
RIS Rx Appoints John Driscoll as Chairman of the Board
RIS Rx, a healthcare technology company focused on helping pharmaceutical manufacturers optimize the patient payment revenue cycle, today announced the appointment of John Driscoll as Chairman of the Board of Directors.
